Additional studies have shown that SSRI users generally have lower Hb concentrations compared to non-users, possibly due to inhibition of platelet serotonin uptake, impairment of platelet aggregation, and prolonged bleeding time, which may result in chronic occult blood loss and secondary anemia. This evidence concerns the gene GSTM1 and anemia.